Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan.

Literature DB >> 10865985

Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan.

K Miyazawa, J Nishimaki, K Ohyashiki, S Enomoto, S Kuriya, R Fukuda, T Hotta, M Teramura, H Mizoguchi, T Uchiyama, M Omine.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2000 PMID： 10865985 DOI： 10.1038/sj.leu.2401790

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2.

Authors: Junichi Kitagawa; Takeshi Hara; Hisashi Tsurumi; Soranobu Ninomiya; Kengo Ogawa; Seiji Adachi; Nobuhiro Kanemura; Senji Kasahara; Masahito Shimizu; Hisataka Moriwaki
Journal: J Cancer Res Clin Oncol Date: 2010-07-31 Impact factor: 4.553

2. Assessment of the international prognostic scoring system for determining chemotherapeutic indications in myelodysplastic syndrome: Japanese retrospective multicenter study.

Authors: Yoshikazu Ito; Kazuma Ohyashiki; Hisamaru Hirai; Seishi Ogawa; Kinuko Mitani; Tomomitsu Hotta; Masami Bessho; Tomoki Naoe; Hideaki Mizoguchi; Takashi Uchiyama; Mitsuhiro Omine
Journal: Int J Hematol Date: 2005-10 Impact factor: 2.490

3. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.

Authors: Akihiko Tsuchida; Takao Itoi
Journal: World J Gastrointest Oncol Date: 2010-03-15

4. Regression of hepatocellular carcinoma during vitamin K administration.

Authors: Kazuhiro Nouso; Shuji Uematsu; Kunihiro Shiraga; Ryoichi Okamoto; Ryo Harada; Shoko Takayama; Wakako Kawai; Shigeru Kimura; Toru Ueki; Nobuaki Okano; Masahiro Nakagawa; Motowo Mizuno; Yasuyuki Araki; Yasushi Shiratori
Journal: World J Gastroenterol Date: 2005-11-14 Impact factor: 5.742

Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan.

1. Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2.

2. Assessment of the international prognostic scoring system for determining chemotherapeutic indications in myelodysplastic syndrome: Japanese retrospective multicenter study.

3. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.

4. Regression of hepatocellular carcinoma during vitamin K administration.

5. Vitamin K homologs as potential biomarkers for disease activity in patients with rheumatoid arthritis.

Review 6. Research progress on the anticancer effects of vitamin K2.

7. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.